The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.
Russell Cohen, MD(Moderator)
Professor of Medicine
Directory, Inflammatory Bowel Disease Center
Co-Director, Advanced IBD Fellowship Program
University of Chicago Medical Center
William Rigby, MD (Faculty)
Professor of Medicine, Microbiology and Immunology
Division of Rheumatology
Vice Chairman, Academic Affairs
Department of Medicine
Dartmouth Medical School
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Joel Pekow, MD (Faculty)
Assistant Professor of Medicine
Section of Gastroenterology, Hepatology and Nutrition
University of Chicago Medicine and Biological Sciences
The following financial relationships have been provided:
Russell Cohen, MD
Speakers’ Bureau: AbbVie, Takeda Pharmaceuticals, Inc.
Consultant/Advisory Board: AbbVie, Celgene Corporation, Entera Health, Inc., Hospira, Janssen, Pfizer, Inc., Sandoz Biopharmaceuticals, Takeda Pharmaceuticals, Inc., UCB S.A.
Clinical Investigator: AstraZeneca, Celgene Corporation, Gilead Sciences, Inc., MedImmune, Mesoblast Ltd., Osiris Therapeutics, Inc., Pfizer Inc., Receptos, RedHill Biopharma, Sanofi-Aventis, USB S.A.
William Rigby, MD
Consulting Agreements: Bristol-Myers Squibb, Pfizer Inc., Roche
Joel Pekow, MD
Sources of Funding for Research: AbbVie, Takeda Pharmaceuticals, Inc.
Consultant/Advisory Board: Janssen, Pfizer, Inc., Verastem Inc.
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: JAK inhibitors under investigation for RA and IBD.
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.